Abstract BACKGROUND Cardiac troponins I (cTnI) and T (cTnT) have received international
endorsement as the standard biomarkers for detection of myocardial injury, for risk …

Abstract BACKGROUND Cardiac troponin I (cTnI) and cardiac troponin T (cTnT)
determinations are fixtures in clinical practice and research. Cardiac troponin testing has …

Despite the facts that cardiac troponin was introduced 2 decades ago and has been
established since 2000 as the preferred biomarker for the diagnosis of myocardial infarction …

Implementation of cardiac troponin (cTn) assays has revolutionized the diagnosis, risk
stratification, triage and management of patients with suspected myocardial infarction (MI) …

Abstract The International Federation of Clinical Chemistry Committee on Clinical
Application of Cardiac Bio-Markers provides evidence-based educational documents to …

Despite continuous advances in troponin assays, there is still significant room for
improvement, particularly in the area of assay standardization and elimination of …

The high-sensitivity immunoassays for cardiac troponin I (hs-cTnI) and cardiac troponin T (hs-
cTnT) are recommended by all the most recent international guidelines as gold standard …

Current guidelines worldwide recommend cardiac troponins I (cTnI) and T (cTnT) as the
biomarkers of choice for the differential diagnosis of acute coronary syndrome (ACS), and …

Troponin quality specifications describing the pre-analytical, analytical and post-analytical
performance of cardiac troponin (cTn) assays are important for both manufacturers of cTn …

Standardization of cardiac troponin I (cTnI) measurement is important because of the central
role for diagnosis of myocardial infarction. In blood, cTnI is present as a heterogeneous …